Loading...
6539 logo

DV Biomed Co., Ltd.TPEX:6539 Stock Report

Market Cap NT$978.8m
Share Price
n/a
1Y-33.6%
7D0.5%
1D0%
Portfolio Value
View

DV Biomed Co., Ltd.

TPEX:6539 Stock Report

Market Cap: NT$978.8m

DV Biomed (6539) Stock Overview

Manufactures and sells medical-grade skin care products in Taiwan and China. More details

6539 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends1/6

6539 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW477,399 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
477,399 investors already sharing narratives

DV Biomed Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DV Biomed
Historical stock prices
Current Share PriceNT$40.20
52 Week HighNT$60.80
52 Week LowNT$38.95
Beta0.067
1 Month Change-5.41%
3 Month Change-16.16%
1 Year Change-33.56%
3 Year Change-74.38%
5 Year Change-72.16%
Change since IPO-79.82%

Recent News & Updates

Recent updates

Analysis Article Mar 22

How Does DV Biomed Co., Ltd. (GTSM:6539) Stand Up To These Simple Dividend Safety Checks?

Could DV Biomed Co., Ltd. ( GTSM:6539 ) be an attractive dividend share to own for the long haul? Investors are often...
Analysis Article Jan 27

DV Biomed Co., Ltd.'s (GTSM:6539) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at DV Biomed's (GTSM:6539) recent performance, when its stock has declined 4.2...
Analysis Article Jan 07

DV Biomed's (GTSM:6539) Earnings Are Growing But Is There More To The Story?

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Analysis Article Dec 10

Should DV Biomed (GTSM:6539) Be Disappointed With Their 37% Profit?

Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...
Analysis Article Nov 19

Are You An Income Investor? Don't Miss Out On DV Biomed Co., Ltd. (GTSM:6539)

Today we'll take a closer look at DV Biomed Co., Ltd. (GTSM:6539) from a dividend investor's perspective. Owning a...

Shareholder Returns

6539TW Personal ProductsTW Market
7D0.5%1.4%3.1%
1Y-33.6%-27.9%82.0%

Return vs Industry: 6539 underperformed the TW Personal Products industry which returned -27.9% over the past year.

Return vs Market: 6539 underperformed the TW Market which returned 82% over the past year.

Price Volatility

Is 6539's price volatile compared to industry and market?
6539 volatility
6539 Average Weekly Movement4.8%
Personal Products Industry Average Movement4.4%
Market Average Movement6.5%
10% most volatile stocks in TW Market12.1%
10% least volatile stocks in TW Market2.7%

Stable Share Price: 6539 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6539's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/aLiqi Zhangwww.dvbiomed.com

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skincare; and beauty products and services, as well as operates beauty therapy centers.

DV Biomed Co., Ltd. Fundamentals Summary

How do DV Biomed's earnings and revenue compare to its market cap?
6539 fundamental statistics
Market capNT$978.84m
Earnings (TTM)NT$8.09m
Revenue (TTM)NT$794.18m
121.0x
P/E Ratio
1.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6539 income statement (TTM)
RevenueNT$794.18m
Cost of RevenueNT$227.55m
Gross ProfitNT$566.63m
Other ExpensesNT$558.54m
EarningsNT$8.09m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.33
Gross Margin71.35%
Net Profit Margin1.02%
Debt/Equity Ratio0%

How did 6539 perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
181%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/08 03:11
End of Day Share Price 2026/08/07 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DV Biomed Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.